Medicare coverage

Actionable Insights Powered by AI

Lilly and Novo Nordisk Near White House Deal to Cut Obesity Drug Prices

Lilly; Novo Nordisk; White House; obesity drug prices; Medicare coverage; GLP-1 medications; Trump administration; Zepbound; Wegovy